30 closest matches · ranked by relevance
Diabetes Mellitus, Type 2 · Hypertension · Hyperlipidemia
Primary: Primary Effectiveness Outcome - LDL — 57.9; 54.8 percentage of time spent at goal
Hypertension
Primary: Systolic Blood Pressure — 134.5; 141.7; 134.6 mm Hg
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Electronic Health Records
Primary: Amount of Time to Complete Assessment and Plan — 8.5; 8.7 minutes — p=0.047
Medication Adherence
Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)
Medication Adherence · Mobile Application
Primary: Usability of the SAM App — 1.14; 1.32; 1.35; 1.81 score on a scale
Diabetes Mellitus · Hypertension · Hyperlipidemia
Primary: Percent of Participants With Adherence at Month 6 — 91; 40 percent persistent on therapy — p=<0.05
Adherence
Primary: Medication Adherence - Pill Count — 0.46; 0.53 Probability of adherence (PT/PP => 0.8) — p=0.04
Polypharmacy · Dementia · Multiple Chronic Conditions
Primary: Preliminary Efficacy of the Intervention to be Assessed From Primary Care Clinician's Intervention Visit Clinical Notes and EHR — 15; 7; 7; 7 Participants
Heart Failure
Primary: Feasibility of AMDD to Improve Medication Adherence Via Completion Rate — 15 participants
Polypharmacy
Primary: Medication Reconciliation — 0.14; 0.17 number of discrepancies per medication
Type 2 Diabetes
Primary: Prescription Understanding — 0.81; 0.82; 0.78 Probability
Feedback, Psychological · Clinical Trial · Substance Abuse
Primary: Change in Past 6 Month Non-Medical Use of Prescription Stimulant Medication Frequency — -2.04; -1.72; -1.03; -.38 Usage days — p=0.03
Schizophrenia
Primary: Antipsychotic Medication Adherence — 63.9; 75.0 percentage of participants — p=0.03
Medication Adherence
Primary: Medication Adherence — 94.8; 82.8 percentage of doses taken
Polypharmacy · Alzheimer Disease and Related Dementias
Primary: Feasibility as Assessed by Proportion of Dyads That Opt Out of the Intervention — 101; 122; 132; 69 Participants
Bipolar Disorder
Primary: Change in Treatment Non-adherence as Measured by the Tablets Routine Questionnaire (TRQ) (Past Month) — -23.6 percentage of medication not taken — p=<0.001
Hypertension · Diabetes · Hypercholesterolemia
Primary: Medication Possession Ratio at Baseline — 65.0 percentage of medication possession
Cardiovascular Diseases · Heart Diseases · Hypertension
Primary: Behaviors Risk Score — 17.9; 16.6; 16.4; 12.6 units on a scale — p=0.035
Medication Adherence
Primary: Medication Adherence — 88.1; 96.6; 94.4 percentage of doses taken (pill count)
Attention Deficit Hyperactivity Disorder
Primary: Proportion of Days Covered With Medicine — 0.69 Proportion of days covered with medicine
Alzheimer's Disease
Primary: Mini-mental State Examination (MMEE) — 12; 12 score — p=0.23
Medication Adherence · Self Efficacy
Primary: Change in Medication Adherence as Measured by the Adherence to Refills and Medications Scale (ARMS) — -4.0; -1.0 score on a scale
Diabetes · Hypertension
Primary: Measure of Medication Self-Management (MeDS) — 10.9; 2.5 units on a scale — p=<.001
Major Depressive Disorder
Primary: Hamilton Rating Scale for Depression — 25; 31 units on a scale
Machine Intelligence in the Pharmacy
Primary: Reaction Time — 3668; 4727; 4510 millisecond (ms)
Attention Deficit Hyperactivity Disorder · Adherence, Medication
Primary: Proportion of Days Covered With Medicine — 0.24; 0 proportion of days covered with medicine — p=0.08
Drug-Related Side Effects and Adverse Reactions · Adverse Drug Events
Primary: Medication Discrepancies — 6.4; 4.4 Medication Discrepancies
Hypertension
Primary: In-clinic Blood Pressure Change — 136.0; 140.3; 126.9; 136.1 mm Hg — p=0.72
Adherence, Medication · Nonadherence, Medication
Primary: Median Proportion of Days Covered (PDC) at 8-months Post-enrollment — 0.94; 0.88 proportion of days covered (PDC) — p=0.001